Introduction: Lipoid proteinosis (LP), a rare autosomal recessive disorder typified by generalized thickening of the skin, mucosa, and certain viscera, is associated with pathogenic ECM1 variants. Skin lesions like beaded eyelid papules, acneiform scars, wavy, yellow papules and nodules typically appear in early childhood. Some patients may exhibit neurological abnormalities like temporal lobe or hippocampi-amygdala complex calcification, epilepsy, and neuropsychiatric abnormalities. Methods: We included 15 individuals with LP from 10 unrelated families. The study includes clinical evaluations of family history, radiological findings, histopathological examination of the skin, and genetic investigations. Results: All affected individuals exhibited skin and mucosal lesions. Among the 15 cases, five (33%) showed neurological symptoms, four (26%) presented neuropsychiatric findings, and three (20%) had diabetes mellitus. We observed characteristic intracranial calcifications in all patients with epileptic seizures. Four out of the five cases with epilepsy and intracranial calcifications also had neuropsychiatric findings. All patients with neurological and neuropsychiatric findings had a frame-shift variant, but the same frame-shift variant was not associated with these findings in other individuals. In our study, no patient with variants other than frame-shift variants exhibited neurological or neuropsychiatric findings. Adrenal calcification, which was observed in 1 patient, was not previously linked to LP. Conclusion: Our study observed diverse variations in LP cases among the Turkish population, with varying clinical presentation even among individuals with identical variations within the same family. In our series, the lack of correlation between genotype and phenotype makes providing specific genetic counseling to families challenging.

1.
Urbach
E
,
Wiethe
C
.
Lipoidosis cutis et mucosae
.
Virchows Arch Path Anat
.
1929
;
273
(
2
):
285
319
.
2.
Hofer
P
.
Urbach–Wiethe disease (lipoglycoproteinosis; lipoid proteinosis; hyalinosis cutis et mucosae). A review
.
Acta Derm Venereol Suppl Stockh
.
1973
;
53
:
1
52
.
3.
Hamada
T
.
Lipoid proteinosis
.
Clin Exp Dermatol
.
2002
;
27
(
8
):
624
9
.
4.
Siebert
M
,
Markowitsch
HJ
,
Bartel
P
.
Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease
.
Brain
.
2003
;
126
(
Pt 12
):
2627
37
.
5.
Thornton
HB
,
Nel
D
,
Thornton
D
,
van Honk
J
,
Baker
GA
,
Stein
DJ
.
The neuropsychiatry and neuropsychology of lipoid proteinosis
.
J Neuropsychiatry Clin Neurosci
.
2008
;
20
(
1
):
86
92
.
6.
Teive
HA
,
Pereira
ER
,
Zavala
JA
, et al
.
Generalized dystonic and striatal calcifications with lipoid proteinosis
.
Neurology
.
2004
;
63
:
2168
2169
.
7.
Chan
I
,
Liu
L
,
Hamada
T
,
Sethuraman
G
,
McGrath
JA
.
The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1
.
Exp Dermatol
.
2007
;
16
(
11
):
881
90
.
8.
Sercu
S
,
Zhang
M
,
Oyama
N
,
Hansen
U
,
Ghalbzouri
AEL
,
Jun
G
, et al
.
Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin
.
J Invest Dermatol
.
2008
;
128
(
6
):
1397
408
.
9.
van Hougenhouck-Tulleken
W
,
Chan
I
,
Hamada
T
, et al
.
Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa
.
Br J Dermatol
.
2004
;
151
:
413
423
.
10.
LeWitt
TM
,
Palmer
AS
,
Bell
A
,
Xiaolong
A
.
Lipoid proteinosis
. In:
StatPearls
.
StatPearls Publishing
;
2023
.
11.
Hamada
T
,
Wessagowit
V
,
South
AP
,
Ashton
GHS
,
Chan
I
,
Oyama
N
, et al
.
Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype–phenotype correlation
.
J Invest Dermatol
.
2003
;
120
(
3
):
345
50
.
12.
Akoglu
G
,
Karaduman
A
,
Ergin
S
,
Erkin
G
,
Gokoz
O
,
Unal
OF
, et al
.
Clinical and histopathological response to acitretin therapy in lipoid proteinosis
.
J Dermatolog Treat
.
2011
;
22
(
3
):
178
83
.
13.
Dertlioglu
SB
,
Edgünlü
TG
,
Şen
DE
,
Süzek
.
Extracellular matrix protein 1 gene mutation in Turkish patients with lipoid proteinosis
.
Indian J Dermatol
.
2019
;
64
(
6
):
436
40
.
14.
Eser
HC
,
Ayyildiz Emecen
D
,
Topyildiz
E
,
Isik
E
,
Edeer Karaca
N
,
Atik
T
, et al
.
Dual diagnosis of trichohepatoenteric syndrome and lipoid proteinosis in a Turkish child
.
Mol Syndromol
.
2023
;
14
(
6
):
504
8
.
15.
Taşdelen
E
,
Sezer
A
,
An
I
.
A founder deletion in ECM1 of 1163 bp causes lipoid proteinosis in the southeast region of Turkiye
.
Am J Med Genet
.
2024
;
194
(
10
):
e63782
.
16.
Rey
LK
,
Kohlhase
J
,
Möllenhoff
K
,
Dekomien
G
,
Epplen
JT
,
Hoffjan
S
.
A novel ECM1 splice site mutation in lipoid proteinosis: case report plus review of the literature
.
Mol Syndromol
.
2016
;
7
(
1
):
26
31
.
17.
Salih
MA
,
Abu-Amero
KK
,
Alrasheed
S
,
Alorainy
IA
,
Liu
L
,
McGrath
JA
, et al
.
Molecular and neurological characterizations of three Saudi families with lipoid proteinosis
.
BMC Med Genet
.
2011
;
12
:
31
.
18.
Youssefian
L
,
Vahidnezhad
H
,
Daneshpazhooh
M
,
Abdollahzadeh
S
,
Talari
H
,
Khoshnevisan
A
, et al
.
Lipoid proteinosis: phenotypic heterogeneity in Iranian families with c.507delT mutation in ECM1
.
Exp Dermatol
.
2015
;
24
(
3
):
220
2
.
19.
Townsend
SE
,
Gannon
M
.
Extracellular matrix-associated factors play critical roles in regulating pancreatic β-cell proliferation and survival
.
Endocrinology
.
2019
;
160
(
8
):
1885
94
.
20.
Shawky
RM
.
Reduced penetrance in human inherited disease
.
Egypt J Med Hum Genet
.
2014
;
15
(
2
):
103
11
.
You do not currently have access to this content.